Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Smartphone mood tracking may predict Post-Stroke depression

NCT ID NCT04043052

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This study tested whether daily mood check-ins via a mobile app could help predict and prevent depression in people who recently had a stroke. Over 400 participants used the app for three months while researchers tracked their emotional symptoms. The goal was to see if this kind of monitoring could identify those at risk early, so doctors could step in sooner.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Assistance Publique Hopitaux de Paris - Groupe Hospitalier Paris Saint Joseph

    Paris, 75 014, France

  • CHRU de Brest

    Brest, 29 609, France

  • CHU Dijon Bourgogne

    Dijon, 21 079, France

  • CHU de Bordeaux

    Bordeaux, 33 076, France

  • CHU de Montpellier

    Montpellier, 34295, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Ecological Momentary Assessment (EMA) via mobile app

What this could lead to

If successful, this approach could help doctors identify stroke patients at high risk for depression early and offer timely support.

What could go wrong

This is an observational study, not a treatment trial. It tests monitoring, not prevention, so it may not directly reduce depression rates.

Conditions

The condition(s) this trial relates to.

anxiety disorder Depression depressive disorder hemorrhagic stroke ischemic stroke stroke disorder transient ischemic attack

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.